help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jakobovitz, O.
Right arrow Articles by Friedman, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jakobovitz, O.
Right arrow Articles by Friedman, E.

Journal of Clinical Endocrinology & Metabolism, Vol 81, 3164-3167, Copyright © 1996 by Endocrine Society


ARTICLES

Carcinoid tumors frequently display genetic abnormalities involving chromosome 11

O Jakobovitz, D Nass, L DeMarco, AJ Barbosa, FB Simoni, G Rechavi and E Friedman
Oncogenetics Unit, Chaim Sheba Medical Center, Tel-Hashomer, Israel.

Carcinoid tumors are neuroendocrine neoplasms that are encountered either sporadically or as part of a familial syndrome, most notably- multiple endocrine neoplasia type 1 (MEN1). The MEN1 gene localizes to chromosome 11 (11q13) and presumably functions as a tumor suppressor gene. The molecular mechanisms underlying carcinoid tumor development and their clonal composition remain largely unknown. To establish whether carcinoid tumors develop via a mechanism similar to other MEN1- associated tumors, and indirectly determine their clonal composition, we analyzed 36 sporadically occurring carcinoid tumors with 16 chromosome 11 microsatellite markers, mostly from around the MEN1 region for loss of heterozygosity (LOH). Twenty one tumors (58%) displayed LOH of at least three markers, five lost almost an entire allele and the rest displayed a discontinuous pattern. Similar, but less extensive analysis was also carried out for 10 additional carcinoid tumors from Brazil, 6 of the 10 showed LOH with at least one marker. Overall, 36 of 46 tumors (78%) displayed LOH. In addition, 20 of 46 (43%) tumors exhibited a pattern of genomic instability. Thus, the majority of sporadically occurring carcinoid tumors are monoclonal whose tumorigenesis involves inactivation of a tumor suppressor gene on chromosome 11 and DNA mismatch repair genes mutations.


This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
M. M. Hassan, A. Phan, D. Li, C. G. Dagohoy, C. Leary, and J. C. Yao
Family History of Cancer and Associated Risk of Developing Neuroendocrine Tumors: A Case-Control Study
Cancer Epidemiol. Biomarkers Prev., April 1, 2008; 17(4): 959 - 965.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J. C. Yao, J. X. Zhang, A. Rashid, S.-C. J. Yeung, J. Szklaruk, K. Hess, K. Xie, L. Ellis, J. L. Abbruzzese, and J. A. Ajani
Clinical and In vitro Studies of Imatinib in Advanced Carcinoid Tumors
Clin. Cancer Res., January 1, 2007; 13(1): 234 - 240.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
D. Furlan, R. Cerutti, S. Uccella, S. La Rosa, E. Rigoli, A. Genasetti, and C. Capella
Different Molecular Profiles Characterize Well-Differentiated Endocrine Tumors and Poorly Differentiated Endocrine Carcinomas of the Gastroenteropancreatic Tract
Clin. Cancer Res., February 1, 2004; 10(3): 947 - 957.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
S. Kytola, A. Hoog, B. Nord, B. Cedermark, T. Frisk, C. Larsson, and M. Kjellman
Comparative Genomic Hybridization Identifies Loss of 18q22-qter as an Early and Specific Event in Tumorigenesis of Midgut Carcinoids
Am. J. Pathol., May 1, 2001; 158(5): 1803 - 1808.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. Serrano, S. U. Goebel, P. L. Peghini, I. A. Lubensky, F. Gibril, and R. T. Jensen
Alterations in the p16INK4a/CDKN2A Tumor Suppressor Gene in Gastrinomas
J. Clin. Endocrinol. Metab., November 1, 2000; 85(11): 4146 - 4156.
[Abstract] [Full Text]


Home page
Am. J. Pathol.Home page
J. Zhao, R. R. de Krijger, D. Meier, E.-J. M. Speel, P. Saremaslani, S. Muletta-Feurer, C. Matter, J. Roth, P. U. Heitz, and P. Komminoth
Genomic Alterations in Well-Differentiated Gastrointestinal and Bronchial Neuroendocrine Tumors (Carcinoids) : Marked Differences Indicating Diversity in Molecular Pathogenesis
Am. J. Pathol., November 1, 2000; 157(5): 1431 - 1438.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
F. Yu, R. T. Jensen, I. A. Lubensky, E. H. Mahlamaki, Y.-L. Zheng, A. M. Herr, and L. J. Ferrin
Survey of Genetic Alterations in Gastrinomas
Cancer Res., October 1, 2000; 60(19): 5536 - 5542.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
I. I. Wistuba, C. Behrens, A. K. Virmani, G. Mele, S. Milchgrub, L. Girard, J. W. Fondon III, H. R. Garner, B. McKay, F. Latif, et al.
High Resolution Chromosome 3p Allelotyping of Human Lung Cancer and Preneoplastic/Preinvasive Bronchial Epithelium Reveals Multiple, Discontinuous Sites of 3p Allele Loss and Three Regions of Frequent Breakpoints
Cancer Res., April 1, 2000; 60(7): 1949 - 1960.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Sarquis, E. Friedman, W. L. Boson, R. S. Gomez, A. F. Dias, and L. De Marco
Microsatellite Instability in Sporadic Parathyroid Adenoma
J. Clin. Endocrinol. Metab., January 1, 2000; 85(1): 250 - 252.
[Abstract] [Full Text]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
D. Babovic-Vuksanovic, C. L. Constantinou, J. Rubin, C. M. Rowland, D. J. Schaid, and P. S. Karnes
Familial Occurrence of Carcinoid Tumors and Association with Other Malignant Neoplasms
Cancer Epidemiol. Biomarkers Prev., August 1, 1999; 8(8): 715 - 719.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
M. S. Turker, B. M. Gage, J. A. Rose, D. Elroy, O. N. Ponomareva, P. J. Stambrook, and J. A. Tischfield
A Novel Signature Mutation for Oxidative Damage Resembles a Mutational Pattern Found Commonly in Human Cancers
Cancer Res., April 1, 1999; 59(8): 1837 - 1839.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
B. Gortz, J. Roth, A. Krahenmann, R. R. de Krijger, S. Muletta-Feurer, K. Rutimann, P. Saremaslani, E. J. M. Speel, P. U. Heitz, and P. Komminoth
Mutations and Allelic Deletions of the MEN1 Gene Are Associated with a Subset of Sporadic Endocrine Pancreatic and Neuroendocrine Tumors and Not Restricted to Foregut Neoplasms
Am. J. Pathol., February 1, 1999; 154(2): 429 - 436.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
A. K. Walch, H. F. Zitzelsberger, M. M. Aubele, A. E. Mattis, M. Bauchinger, S. Candidus, H. W. Prauer, M. Werner, and H. Hofler
Typical and Atypical Carcinoid Tumors of the Lung Are Characterized by 11q Deletions as Detected by Comparative Genomic Hybridization
Am. J. Pathol., October 1, 1998; 153(4): 1089 - 1098.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
I. Shimon and S. Melmed
Pituitary Tumor Pathogenesis
J. Clin. Endocrinol. Metab., June 1, 1997; 82(6): 1675 - 1681.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
Q. Dong, L. V. Debelenko, S. C. Chandrasekharappa, M. R. Emmert-Buck, Z. Zhuang, S. C. Guru, P. Manickam, M. Skarulis, I. A. Lubensky, L. A. Liotta, et al.
Loss of Heterozygosity at 11q13: Analysis of Pituitary Tumors, Lung Carcinoids, Lipomas, and Other Uncommon Tumors in Subjects with Familial Multiple Endocrine Neoplasia Type 1
J. Clin. Endocrinol. Metab., May 1, 1997; 82(5): 1416 - 1420.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1996 by The Endocrine Society